MECHANISM OF CLEARANCE OF CIRCULATING CA19-9 IN RATS

被引:5
作者
ADACHI, M
SEKINE, T
UMEMOTO, A
TSUKIKAWA, S
IMAI, K
YACHI, A
机构
[1] SAPPORO MED COLL,DEPT INTERNAL MED,SECT 1,S 1,W 16,CHUO KU,SAPPORO,HOKKAIDO 060,JAPAN
[2] ST MARIANNA MED UNIV,DEPT SURG,SECT 1,KANAGAWA,JAPAN
[3] NATL CANC CTR,RES INST,DIV BIOCHEM,TOKYO 104,JAPAN
关键词
CA19-9; Clearance; Monoclonal antibody; Sialylated glycoprotein;
D O I
10.1159/000217642
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Molecules bearing the carbohydrate antigen 19-9 (CA19-9) epitope were prepared from serum and ascites of a patient with colon cancer or from the SW 1116 cell culture supernatant. Their plasma clearance mechanism was investigated in rats. The clearance curves of the molecules from three different sources showed a biphasic decrease. The coexistence of epitopes of CA19-9 and desialylated CA19-9 (Lea) in the same molecule was demonstrated by double-determinant enzyme immunoassays. CA19-9-bearing molecules with a low expression of Lea epitope, which were derived from the serum of a patient with colon cancer, showed mainly a slow disappearance, while the molecules with a high expression of Lea epitope from SW 1116 cells showed mainly a rapid disappearance. Thus, the clearance rate of the CA19-9-bearing molecules might be determined by their degrees of sialylation. This observation will be helpful for understanding the in vivo metabolism of CA19-9-bearing molecules. © 1990 S. Karger AG, Basel.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 13 条
[1]  
ADACHI M, 1987, JPN J CANCER RES, V78, P1370
[2]  
BAENZIGER JU, 1980, J BIOL CHEM, V255, P4605
[3]  
Bayer E A, 1979, Methods Enzymol, V62, P308
[4]   COLORECTAL CARCINOMA-SPECIFIC ANTIGEN - DETECTION BY MEANS OF MONOCLONAL ANTIBODIES [J].
HERLYN, M ;
STEPLEWSKI, Z ;
HERLYN, D ;
KOPROWSKI, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (03) :1438-1442
[5]   DETECTION BY MONOCLONAL-ANTIBODY OF CARBOHYDRATE ANTIGEN CA-50 IN SERUM OF PATIENTS WITH CARCINOMA [J].
HOLMGREN, J ;
LINDHOLM, L ;
PERSSON, B ;
LAGERGARD, T ;
NILSSON, O ;
SVENNERHOLM, L ;
RUDENSTAM, CM ;
UNSGAARD, B ;
YNGVASON, F ;
PETTERSSON, S ;
KILLANDER, AF .
BRITISH MEDICAL JOURNAL, 1984, 288 (6429) :1479-1482
[6]  
JOURDIAN GW, 1971, J BIOL CHEM, V246, P430
[7]   COLORECTAL-CARCINOMA ANTIGENS DETECTED BY HYBRIDOMA ANTIBODIES [J].
KOPROWSKI, H ;
STEPLEWSKI, Z ;
MITCHELL, K ;
HERLYN, M ;
HERLYN, D ;
FUHRER, P .
SOMATIC CELL GENETICS, 1979, 5 (06) :957-972
[8]   SPECIFIC ANTIGEN IN SERUM OF PATIENTS WITH COLON-CARCINOMA [J].
KOPROWSKI, H ;
HERLYN, M ;
STEPLEWSKI, Z ;
SEARS, HF .
SCIENCE, 1981, 212 (4490) :53-55
[9]  
KUSAMA K, 1987, JPN J CANCER RES, V78, P952
[10]  
Lenten LV, 1971, J BIOL CHEM, V246, P1889